Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Casi Pharmaceuticals revenue
Casi Pharmaceuticals's revenue is $30.2 million.
What is Casi Pharmaceuticals's revenue?
- Casi Pharmaceuticals annual revenue for 2020 was 15.1M, 266.52% growth from 2019.
- Casi Pharmaceuticals's revenue growth from 2010 to 2021 is 716.86%.
- Casi Pharmaceuticals has 118 employees, and the revenue per employee ratio is $255,661.
- Casi Pharmaceuticals's peak quarterly revenue was $10.2M in 2022(q3).
- Casi Pharmaceuticals peak revenue was $30.2M in 2021.
- Casi Pharmaceuticals annual revenue for 2021 was 30.2M, 99.25% growth from 2020.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Casi Pharmaceuticals historical revenue
Casi Pharmaceuticals's peak revenue was $30.2M in 2021. The peak quarterly revenue was $10.2M in 2022(q3).
Casi Pharmaceuticals's revenue increased from $3.7m in 2010 to $30.2M currently. That's a 716.86% change in annual revenue.
Casi Pharmaceuticals annual revenue
Casi Pharmaceuticals annual revenue over time
| Fiscal year / year | Casi Pharmaceuticals revenue |
|---|---|
| 2010 | $3.7M |
| 2011 | $1.9M |
| 2012 | $669,310 |
| 2014 | $23,727 |
| 2015 | $47,712 |
| 2019 | $4.1M |
| 2020 | $15.1M |
| 2021 | $30.2M |
How accurately did Casi Pharmaceuticals' revenue projections match actual performance?
Casi Pharmaceuticals annual growth
Casi Pharmaceuticals saw the greatest revenue growth in 2019, when revenue increased by 8,558.2%.
Casi Pharmaceuticals had the lowest revenue growth in 2014, when revenue changed by -96.46%.
Casi Pharmaceuticals annual growth rate over time
| Year | Casi Pharmaceuticals growth |
|---|---|
| 2011 | -47%↓ |
| 2012 | -66%↓ |
| 2014 | -96%↓ |
| 2015 | 101%↑ |
| 2019 | 8558%↑ |
| 2020 | 267%↑ |
| 2021 | 99%↑ |
Casi Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Casi Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2011 | - | $8,852 | - | $1.9M |
| 2012 | - | - | - | $670,732 |
| 2014 | - | - | - | $23,727 |
| 2015 | $23,718 | $23,994 | - | - |
| 2019 | - | - | $2.8M | $1.3M |
| 2020 | $3.4M | $2.7M | $4.2M | $4.8M |
| 2021 | $5.7M | $7.2M | $8.1M | $9.2M |
| 2022 | $9.1M | $8.6M | $10.2M | - |
Casi Pharmaceuticals jobs nearby
Do you work at Casi Pharmaceuticals?
Did Casi Pharmaceuticals meet its revenue projections?
Casi Pharmaceuticals financial information
| CEO | Wei-Wu He Ph.d. |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 118 |
| Date Founded | 1991 |
| Headquarters | Rockville, Maryland |
| Number of Locations | 1 |
| Revenue | $30.2M |
| Net Income | -$36,654,000 |
| Gross Proft | $17.6M (2021) |
| PE Ratio | -5.98 |
| Market Capitalization | $219.1M |
| Total Assets | $138,298,000 |
| Ticker | CASI |
Casi Pharmaceuticals jobs you might like
Casi Pharmaceuticals financing
Casi Pharmaceuticals received early financing of $30.0M on 2006-02-13.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $30M | 02/2006 |
| Post Ipo Debt | $20M | 09/2007 |
| Post Ipo Equity | $2.5M | 02/2010 |
| Post Ipo Equity | $10M | 01/2012 |
| Post Ipo Equity | $2.4M | 10/2017 |
| Post Ipo Equity | $50M | 03/2018 |
| Post Ipo Equity | $32.5M | 03/2021 |
Casi Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Oxford Finance LLC | Post Ipo Debt |
| MERRILL LYNCH & CO. INC. | Post Ipo Debt |
| GE Healthcare | Post Ipo Debt |
| Emerging Technology Partners | Post Ipo Equity |
| Accel | Post Ipo Equity |
| ETP Fund | Post Ipo Equity |
| Robert Duggan | Post Ipo Equity |
| IDG Capital | Post Ipo Equity |
Casi Pharmaceuticals competitors
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Theraclone Sciences | - | $470,000 | 2 | - |
| Catalyst Biosciences | - | $105.8M | 21 | - |
| Good Start Genetics | - | $1.9M | 37 | - |
| Deltagen | - | $1.6M | 200 | - |
| Charles River Labs | - | $4.0B | 18,400 | - |
| Raptor Pharmaceuticals | - | - | 125 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Casi Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Casi Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Casi Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Casi Pharmaceuticals. The data presented on this page does not represent the view of Casi Pharmaceuticals and its employees or that of Zippia.
Casi Pharmaceuticals may also be known as or be related to CASI PHARMACEUTICALS INC., CASI Pharmaceuticals, CASI Pharmaceuticals Inc, CASI Pharmaceuticals, Inc., Casi Pharmaceuticals and EntreMed Inc.